AI CAPITAL INTELLIGENCE
天鹜科技 · Series A++ · CNY 200,000,000–900,000,000 (reported range) · 2026-07-13
Financing facts, at a glance
天鹜科技: financing disclosed on 2026-07-13, Series A++, CNY 200,000,000–900,000,000 (reported range). Named investors: 上海国投先导, 国投创新, 聚杰微纤, 宁波甬元兴仑君金创投, 金景资本, 孚腾资本, 财鑫资本. This is the amount disclosed for the financing, not a company valuation or an individual investor commitment.
天鹜科技 is recorded in the Industry AI / Drug discovery & life sciences segment. The disclosed financing is Series A++, with an amount of CNY 200,000,000–900,000,000 (reported range). Named investors include 上海国投先导, 国投创新, 聚杰微纤, 宁波甬元兴仑君金创投, 金景资本, 孚腾资本, 财鑫资本.
- Disclosed company name
- 上海天鹜科技有限公司
- Disclosure date
- 2026-07-13
- Round
- Series A++
- Financing amount
- CNY 200,000,000–900,000,000 (reported range)
- Market coverage
- China
- Sector
- Industry AI / Drug discovery & life sciences
- Product form
- Enterprise software
Disclosed investors
上海国投先导, 国投创新, 聚杰微纤, 宁波甬元兴仑君金创投, 金景资本, 孚腾资本, 财鑫资本
Original sources
Record reviewed as of . Reported ranges and lower bounds are retained. Financing proceeds are not company valuation.